Fonte: Cancer Immunology, Immunotherapy. Unidade: FOB
Assuntos: CARCINOMA DE CÉLULAS ESCAMOSAS, PROLIFERAÇÃO CELULAR, INVASÃO BIOLÓGICA, INTERLEUCINAS
ABNT
PERRI, Graziela et al. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation. Cancer Immunology, Immunotherapy, v. 73, 2024Tradução . . Disponível em: https://doi.org/10.1007/s00262-024-03676-8. Acesso em: 23 ago. 2024.APA
Perri, G., Vilas Boas, V. G., Nogueira, M. R. S., Mello Júnior, E. J. F., Coelho, A. L., Posadas, E. M., et al. (2024). Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation. Cancer Immunology, Immunotherapy, 73. doi:10.1007/s00262-024-03676-8NLM
Perri G, Vilas Boas VG, Nogueira MRS, Mello Júnior EJF, Coelho AL, Posadas EM, Hogaboam C, Cavassani KA, Campanelli AP. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation [Internet]. Cancer Immunology, Immunotherapy. 2024 ; 73[citado 2024 ago. 23 ] Available from: https://doi.org/10.1007/s00262-024-03676-8Vancouver
Perri G, Vilas Boas VG, Nogueira MRS, Mello Júnior EJF, Coelho AL, Posadas EM, Hogaboam C, Cavassani KA, Campanelli AP. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation [Internet]. Cancer Immunology, Immunotherapy. 2024 ; 73[citado 2024 ago. 23 ] Available from: https://doi.org/10.1007/s00262-024-03676-8